Back to results
US 2010/0137303 A1Published application
New compound 255
AssigneeAstraZeneca AB
InventorsSandeep Raghunath Ghorpade, Manoj Ganpat Kale, Shahul Hameed Peer Mohamed, Anand Kumar Venkobachar Raichurkar, David Charles McKinney
Life of this patent
Estimating the term…
Abstract
Compounds of formula (I) and their pharmaceutically acceptable salts are described. Processes for their preparation, pharmaceutical compositions containing them, their use as medicaments and their use in the treatment of bacterial infections are also described.
Claims13
A compound of formula (I):
- wherein
- Y is S or O
- Q is C(═O)NR4, C(═S)NR5, C(═O)O, C(═NH)NR6, C(═NCN)NR7, SO2NR8, C(═O)C(═O)NR9, or C═O, SO2;
- to R4, R5, R6, R7, R8, R9 are independently selected from H, OH, C1-4alkyl, and C3-6 cycloalkyl;
- R1 is C1-6alkyl, C2-6alkenyl, C2-6alkynyl, C1-6alkoxy, C1-6haloalkyl, C1-6haloalkoxy, C3-7 cycloalkyl, aryl, aryl C1-6alkyl or heterocyclyl.
- X is N or CRa wherein Ra is H, F, CH3, OCH3, CN;
- m=0 to 5
- Ring A is a carbocyclic or heterocyclic ring system comprising up to 12 ring atoms and up to 5 heteroatoms each independently selected from N, O and S;
- wherein if said heterocyclyl contains an —NH— moiety that nitrogen may be optionally substituted by a group R10;
- R3 is hydrogen, halo, nitro, cyano, hydroxy, amino, carboxy, carbamoyl, mercapto, sulphamoyl, C1-6alkyl, C2-6alkenyl, C2-6alkynyl, C1-6alkoxy, C1-6alkanoyl, C1-6alkanoyloxy, N-(C1-6alkyl)amino, N,N-(C1-6alkyl)2amino, C1-6alkanoylamino, N-(C1-6alkyl)carbamoyl, N,N-(C1-6alkyl)2carbamoyl, N-(C1-6alkoxy)carbamoyl, N,N-(C1-6alkoxy)2carbamoyl, C1-6alkylS(O)a wherein a is 0 to 2, C1-6alkoxycarbonyl, C1-6alkoxycarbonylamino, N-(C1-6alkyl)sulphamoyl, N,N-(C1-6alkyl)2sulphamoyl, C1-6alkylsulphonylamino, carbocyclyl-R11— or heterocyclyl-R12—;
- wherein R3 may be optionally substituted on carbon by one or more R13;
- and wherein if said heterocyclyl contains an —NH— moiety that nitrogen may be optionally substituted by a group selected from R14;
- substituents on carbon are independently selected from halo, nitro, cyano, hydroxy, amino, carboxy, carbamoyl, mercapto, sulphamoyl, C1-6alkyl, C2-6alkenyl, C2-6alkynyl, C1-6alkoxy, C1-6alkanoyl, C1-6alkanoyloxy, N-(C1-6alkyl)amino, N,N-(C1-6alkyl)2amino, C1-6alkanoylamino, N-(C1-6alkyl)carbamoyl, N,N-(C1-6alkyl)2carbamoyl, N-(C1-6alkoxy)carbamoyl, N,N-(C1-6alkoxy)2carbamoyl, C1-6alkylS(O)a wherein a is 0 to 2, C1-6alkoxycarbonyl, C1-6alkoxycarbonylamino, N-(C1-6alkyl)sulphamoyl, N,N-(C1-6alkyl)2sulphamoyl, C1-6alkylsulphonylamino, carbocyclyl-R15— or heterocyclyl-R16—;
- and wherein if said heterocyclyl contains an —NH— moiety that nitrogen may be optionally substituted by a group selected from R17;
- to and wherein R3 may be directly attached to the C5 position of thiazolopyridine or oxazolopyrdine without ring A, in which case R3 is halogen, cyano, C1-6alkyl, C2-6alkenyl, C2-6alkynyl, C1-6alkoxy, C1-6haloalkyl, C1-6haloalkoxy, C3-7 cycloalkyl, C3-7 cycloalkoxy, N-(C1-6alkyl)amino, N,N-(C1-6alkyl)2amino, N-(C1-6alkyl)amino alkoxy, N,N-(C1-6alkyl)2amino alkoxy, heterocycloalkoxy with 1-5 heteroatoms in it, arylalkoxy, heterocycloalkyl, arylalkyl, N-(C1-6alkyl)aminoalkoxy, N,N-(C1-6alkyl)2aminoalkoxy, C1-6alkylS(O)a wherein a is 0 to 2, C1-6alkoxycarbonyl, C1-6alkoxycarbonylamino, N-(C1-6alkyl)sulphamoyl, N,N-(C1-6alkyl)2sulphamoyl, C1-6alkylsulphonylamino.
- R11, R15 and R16 are independently selected from a direct bond, —O—, —N(R18)—, —C(O)—, —N(R19)C(O)—, —C(O)N(R20)—, —S(O)s—, —SO2N(R21)— or —N(R22)SO2—;
- wherein R18, R19, R20, R21 and R22 are independently selected from hydrogen or C1-6alkyl and s is 0-2;
- and
- R10, R14 and R17 are independently selected from C1-6alkyl, C3-6cycloalkyl, C1-6alkanoyl, C1-6alkylsulphonyl, C1-6alkoxycarbonyl, carbamoyl, N-(C1-6alkyl)carbamoyl, N,N-(C1-6alkyl)carbamoyl, benzyl, benzyloxycarbonyl, benzoyl and phenylsulphonyl;
- R13 and R12 are independently selected from halo, nitro, cyano, hydroxy, trifluoromethoxy, trifluoromethyl, amino, carboxy, carbamoyl, mercapto, sulphamoyl, methyl, ethyl, methoxy, ethoxy, acetyl, acetoxy, methylamino, ethylamino, dimethylamino, diethylamino, N-methyl-N-ethylamino, acetylamino, N-methylcarbamoyl, N-ethylcarbamoyl, N,N-dimethylcarbamoyl, N,N-diethylcarbamoyl, N-methyl-N-ethylcarbamoyl, methylthio, ethylthio, methylsulphinyl, ethylsulphinyl, mesyl, ethylsulphonyl, methoxycarbonyl, ethoxycarbonyl, N-methylsulphamoyl, N-ethylsulphamoyl, N,N-dimethylsulphamoyl, N,N-diethylsulphamoyl or N-methyl-N-ethylsulphamoyl;
- R2 is H, C1-6alkyl, C2-6alkenyl, C2-6alkynyl, C1-6alkoxy, C1-6haloalkyl, C1-6haloalkoxy, C3-7 cycloalkyl, C3-7 cycloalkoxy, N-(C1-6alkyl)amino, N,N-(C1-6alkyl)2amino, N-(C1-6alkyl)amino alkoxy, N,N-(C1-6alkyl)2amino alkoxy, heterocycloalkoxy with 1-5 heteroatoms in it, arylalkoxy, heterocycloalkyl, arylalkyl, N-(C1-6alkyl)aminoalkoxy, N,N-(C1-6alkyl)2aminoalkoxy, C1-6alkylS(O)a wherein a is 0 to 2, C1-6alkoxycarbonyl, C1-6alkoxycarbonylamino, N-(C1-6alkyl)sulphamoyl, N,N-(C1-6alkyl)2sulphamoyl, or C1-6alkylsulphonylamino, or
- R2 is a group
- wherein
- Z is O, S, or NRb wherein Rb is H, C1-6alkyl, C3-7 cycloalkyl, C1-6alkoxyC1-6alkyl, cycloC3-7alkoxyC1-6alkyl;
- alternatively Z may represent a heterocyclic ring system comprising up to 7 ring atoms and up to 5 heteroatoms each independently selected from is N, O and S,
- alternatively Z is absent and the R2 group is directly attached to the thiazolopyridine or oxazolopyridine ring at the C6 position,
- Ring B is a carbocyclic or heterocyclic ring system comprising up to 12 ring atoms and up to 5 heteroatoms each independently selected from N, O and S;
- and wherein if said ring system contains an —NH— moiety that nitrogen may be optionally substituted by a group R10;
- R23 is hydrogen, halo, nitro, cyano, hydroxy, amino, carboxy, carbamoyl, mercapto, sulphamoyl, C1-6alkyl, C2-6alkenyl, C2-6alkynyl, C1-6alkoxy, C1-6alkanoyl, C1-6alkanoyloxy, N-(C1-6alkyl)amino, N,N-(C1-6alkyl)2amino, C1-6alkanoylamino, N-(C1-6alkyl)carbamoyl, N,N-(C1-6alkyl)2carbamoyl, N-(C1-6alkoxy)carbamoyl, N,N-(C1-6alkoxy)2carbamoyl, C1-6alkylS(O)a wherein a is 0 to 2, C1-6alkoxycarbonyl, C1-6alkoxycarbonylamino, N-(C1-6alkyl)sulphamoyl, N,N-(C1-6alkyl)2sulphamoyl, C1-6alkylsulphonylamino, carbocyclyl-R11— or heterocyclyl-R12—;
- wherein the carbocyclyl or heterocyclyl may be optionally substituted on carbon by one or more R13;
- and wherein if said heterocyclyl contains an —NH— moiety that nitrogen may be optionally substituted by a group R14;
- or alternatively Ring B may be absent and R23 is directly attached to —(CH2)m—, in which case R23 is selected from halogen, cyano, C1-6alkyl, C2-6alkenyl, C2-6alkynyl C1-6alkoxy, C1-6haloalkyl, C1-6haloalkoxy, C3-7 cycloalkyl, C3-7 cycloalkoxy, N-(C1-6alkyl)amino, N,N-(C1-6alkyl)2amino, N-(C1-6alkyl)amino alkoxy, N,N-(C1-6alkyl)2amino alkoxy, heterocycloalkoxy with 1-5 heteroatoms in it, arylalkoxy, heterocycloalkyl, arylalkyl, N-(C1-6alkyl)aminoalkoxy, N,N-(C1-6alkyl)2aminoalkoxy, C1-6alkylS(O)a wherein a is 0 to 2, C1-6alkoxycarbonyl, C1-6alkoxycarbonylamino, N-(C1-6alkyl)sulphamoyl, N,N-(C1-6alkyl)2sulphamoyl, C1-6alkylsulphonylamino;
- or a pharmaceutically acceptable salt thereof.
30 more elements
Dependencies are inferred from the claim text.